Document Detail

Quality of life on antihypertensive therapy: a double-blind trial comparing quality of life on pinacidil and nifedipine in combination with a thiazide diuretic. European Pinacidil Study Group.
MedLine Citation:
PMID:  1383618     Owner:  NLM     Status:  MEDLINE    
The quality of life (QL) was evaluated in a 6 month double-blind trial in six European countries. Patients with a sustained supine diastolic blood pressure (SDBP), phase V, of 95 mm Hg or more on bendrofluazide, 5 mg daily (or an equivalent dose of a thiazide diuretic) were randomised to additional pinacidil (n = 127), 25 mg up to 100 mg daily, or nifedipine (n = 130), 20 mg up to 80 mg daily. The treatment groups were similar at entry for QL scores, average DBP of 103 +/- 6 (SD) mm Hg, and average age of 56 +/- 10 (SD) years. Eighteen patients on pinacidil and 12 on nifedipine withdrew due to side effects, such as oedema (both drugs) and flushing (nifedipine). The maximum antihypertensive effect was achieved within 6 weeks and maintained, resulting in a significant fall in SDBP of 13.7 mm Hg on pinacidil and 15.5 mm Hg on nifedipine at the end of the trial. There was no significant difference in the antihypertensive effect. The target SDBP was achieved in 57% of pinacidil-and 63% of nifedipine-treated patients. The average number of symptomatic complaints fell in both groups, with significant decreases in the reporting of blurred vision and headaches on nifedipine. Complaints of growth of body and facial hair increased on pinacidil but there were no significant between-drug comparisons with respect to side effects. In measures of psychological well being, patients on pinacidil showed a significant (p less than 0.05) improvement in total and cognitive function scores compared to nifedipine.(ABSTRACT TRUNCATED AT 250 WORDS)
A E Fletcher; C Battersby; P Adnitt; N Underwood; H J Jurgensen; C J Bulpitt
Related Documents :
20360618 - Does nebivolol influence serum concentrations of proinflammatory cytokines in hypertens...
20111008 - Meta-analysis of dose-response characteristics of hydrochlorothiazide and chlorthalidon...
367678 - Atenolol and chlorthalidone on blood pressure, heart rate, and plasma renin activity in...
2868748 - Studies with fenoldopam, a dopamine receptor da1 agonist, in essential hypertension.
10227448 - Amifostine as a protector against cisplatin-induced toxicity in nude mice.
2873078 - Cardiovascular and renal effects of buspirone in several animal models.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  20     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:  1992 Jul 
Date Detail:
Created Date:  1992-11-04     Completed Date:  1992-11-04     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  108-14     Citation Subset:  IM    
Department of Medicine, Hammersmith Hospital, London, U.K.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antihypertensive Agents / adverse effects,  therapeutic use
Bendroflumethiazide / therapeutic use
Blood Pressure / drug effects
Data Interpretation, Statistical
Double-Blind Method
Drug Therapy, Combination
Guanidines / adverse effects,  therapeutic use*
Hypertension / drug therapy*
Middle Aged
Nifedipine / adverse effects,  therapeutic use*
Quality of Life*
Sodium Chloride Symporter Inhibitors / therapeutic use*
Reg. No./Substance:
0/Antihypertensive Agents; 0/Diuretics; 0/Guanidines; 0/Sodium Chloride Symporter Inhibitors; 21829-25-4/Nifedipine; 73-48-3/Bendroflumethiazide; 85371-64-8/Pinacidil

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Contractile actions of endothelin-1 in isolated helical strips from rat pulmonary artery: potentiati...
Next Document:  Comparison of KRN2391 with nicorandil and nifedipine on canine coronary blood flow: antagonism by gl...